Clinical Trial Update: A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox [Phase 2]

View source ↗

Summary

This Phase 2 randomized multisite trial evaluating the MVA-BN mpox vaccine for monkeypox has completed, and results have been posted to inform public health str…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• JYNNEOS (Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN))

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Monkeypox | Phase 2 | Status: COMPLETED | Results posted: 2026-03-27